학술논문

Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2020, 31 pS711-pS712, 2p. Supplement: 4
Subject
Language
English
ISSN
15698041